Skip to content

Ultrasound, Peds Body Composition, and Neurodevelopmental Outcomes

Use of Bedside Ultrasound to Monitor Body Composition and Neurodevelopmental Outcomes in Formerly-Premature Toddlers

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03479515
Enrollment
80
Registered
2018-03-27
Start date
2018-07-20
Completion date
2023-06-06
Last updated
2025-02-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Prematurity

Brief summary

The overall objective of the proposal is to evaluate the ability of ultrasound to predict the body composition of toddlers in the outpatient clinical setting and to evaluate the relationship between body composition and neurodevelopment.

Detailed description

The investigators will address the hypothesis in the following Specific Aims: Specific Aim 1: Validate ultrasound as a method to measure whole body fat mass and fat-free mass in toddlers. Body composition will be assessed using ultrasound measurements and the validated method of air displacement plethysmography (ADP). Specific Aim 2: Determine the effect of a handheld Force-Measuring Ultrasound Probe on intra- and inter-observer variability in ultrasound measurements. A device which measures the force applied to the ultrasound probe will be used to obtain measurements of muscle and adipose tissue thickness (biceps, abdomen, and quadriceps) in toddlers.

Interventions

DEVICEUltrasound

Ultrasound, ADP, bioimpedance measurements

Sponsors

University of Minnesota
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
2 Years to 4 Years
Healthy volunteers
No

Inclusion criteria

* toddlers who were ≤ 36 weeks gestational age (GA) at birth who attend the University of Minnesota Masonic Children's Hospital NICU Follow Up Clinic * written consent obtained from a parent before or at time of visit

Exclusion criteria

* toddlers who require medical support that prevents them from having ADP measurements taken * those with an inability to sit in a supported seat for 5 minutes * those weighing less than 10 kg

Design outcomes

Primary

MeasureTime frameDescription
Ultrasound Measurementsthrough study completion, up to 2 yearsTissue thickness (adipose and muscle) will be measured in cm using the ultrasound probe.

Secondary

MeasureTime frameDescription
Body Composition Measurementsthrough study completion, up to 2 yearsFat and fat-free mass will be measured in kilograms using bioimpedance and air displacement plethysmography.
Neurodevelopmental Status for 2 year oldsthrough study completion, up to 2 yearsBayley Scales of Neurodevelopment III will be used to measure neurodevelopmental status at 2 years of age, including cognition, language, and motor scores (composite scoring for each area: Cognitive, 55-145; Language, 47-153; Motor, 46-154).
Neurodevelopmental Status for 3 and 4 year oldsthrough study completion, up to 2 yearsWeschler Preschool and Primary Scale of Intelligence (WPPSI) at 3 and 4 years of age will be used to measure neurodevelopmental status for toddlers 3, 4, or 5 years of age. Quotient and Composite scores have a mean of 100 and a standard deviation of 15. Subtest scaled scores have a mean of 10 and a standard deviation of 3.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026